Skip to main content
Caplight Logo









Defibrio AS

Defibrio AS

Private
Arlington, MassachusettsHealthcare & Life Scienceshttps://defibrio.com/

Last Round

VC Round

Jun 18, 2025

Total Funding Raised

$12.4M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Defibrio AS is a healthtech company that develops smartphone-powered automated external defibrillators (AEDs) designed to provide accessible and cost-effective emergency cardiac care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2C

Customer Profile

Hardware + Subscription

AI Layer

Application

Keywords

AEDautomated external defibrillatorpersonal defibrillatormedtechsmartphone-powered medical devicecardiac arrest emergencyrhythm-recognition algorithmmHealthmobile health appportable medical devicehealth IoTemergency preparednessrazor and blade modelconsumer medical techhome safety device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Defibrio AS Comparables

Compare Defibrio AS with similar companies based on industry and business-model similarity.

Defibrio AS comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HeartHero, Inc.
84%
Rapid Response Revival Research Limited
82%
Avive
74%

Defibrio AS Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 18, 2025
SeedMar 1, 2022

Key People

Founding team and executive leadership

Josh Hale

Chief Product Officer

Executive Team

Defibrio AS Investors

Notable investors and investment history

Defibrio AS investors
InvestorRounds
Rieber & SønVC Round
KistefosVC Round
ProVentureVC Round, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 32% MoM.

  • Jun 25, 2026

    Monthly visitors grew 292% MoM, reaching 2.2K.

Defibrio AS Filings

Explore SEC and related filing metadata, where available.

Defibrio AS filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Defibrio AS's valuation, stock price, and market status.

Is Defibrio AS a public or private company?

Defibrio AS is a private company.

What is the current stock price of Defibrio AS?

Defibrio AS is a private company with no public stock price. No recent secondary market data is available.

How much is Defibrio AS worth (valuation)?

Valuation information for Defibrio AS is not publicly available.

Can I buy Defibrio AS stock?

Defibrio AS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Defibrio AS's last funding round?

Defibrio AS's most recent funding round was VC Round on June 18, 2025.

Who are the main investors in Defibrio AS?

Key investors in Defibrio AS include Kistefos.

Will Defibrio AS IPO soon?

No public IPO plans have been announced for Defibrio AS.

How can I track Defibrio AS secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Defibrio AS's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersArlington, Massachusetts
Employee Range4
Year Founded2020
Last FundingJun 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?